High cardiovascular health was associated with a reduced effect of insulin resistance on all-cause and cardiovascular mortality risk.

A Cornell University project to save babies born with serious heart defects has lost key funding just days after it was approved.

Topline results were announced from a phase 3 study comparing aficamten with metoprolol in adults with symptomatic obstructive hypertrophic cardiomyopathy.

The FDA approved 3 new color additives, a move that will provide manufacturers with a wider range of natural color options to safely be used in food.

Men with gout and obesity receiving febuxostat-based ULT were less likely to achieve SU targets and more frequently experienced disease flares.

The head of the FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

The FDA has approved the SAPIEN 3 platform, a TAVR therapy, for patients with severe aortic stenosis without symptoms.

Over a 10-year period, METS-IR effectively predicted CV events among patients with PsA, with values greater than 2.48 at baseline conferring the greatest risk.

President Donald Trump has chosen Dr Casey Means, a wellness influencer and health tech entrepreneur, to be his nominee for surgeon general.

No significant association was observed between viremia history during ART and CVD risk in a large international cohort of patients with HIV infection.

Survival outcomes have improved since 2014 among young, competitive athletes with SCA, although these improvements are mostly among White patients.

A study has found that use of the Organ Care System for heart donation after brain death has favorable post-transplantation outcomes.